...
首页> 外文期刊>Journal of Korean medical science. >Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
【24h】

Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women

机译:韩国女性卵巢癌预测中HE4,CA125和卵巢恶性算法风险的比较

获取原文
           

摘要

This study is a multi-center clinical study, which aimed to compare CA125, HE4, and risk of ovarian malignancy algorithm (ROMA) in predicting epithelial ovarian cancer of Korean women with a pelvic mass. Prospectively, serum from 90 Korean women with ovarian mass was obtained prior to surgery. For control group, serum from 79 normal populations without ovarian mass was also obtained. The HE4 and CA125 data were registered and evaluated separately and ROMA was calculated for each sample. Total 67 benign tumors and 23 ovarian cancers were evaluated. Median serum levels of HE4 and CA125, and ROMA score were significantly higher in patients with ovarian cancer than those with benign ovarian tumor and normal population ( P Go to: Graphical Abstract
机译:该研究是一种多中心临床研究,旨在比较Ca125,He4,He4和卵巢恶性算法(ROMA)的风险预测脑膜骨质的上皮卵巢癌。前瞻性地,在手术前获得了来自90名韩国妇女的血清。对于对照组,还获得了79个没有卵巢质量的正常群体的血清。单独注册和评估HE4和CA125数据,针对每个样品计算ROMA。评估总67个良性肿瘤和23例卵巢癌。卵巢癌患者的He4和Ca125的中位血清水平和罗姆人得分显着高于卵巢肿瘤和正常人群的患者(P转到:图形摘要

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号